Faslodex Articles
News briefs from Bayer, AstraZeneca and Valeant/Galderma
6 December 2012
News briefs: Bayer's Stivarga and AstraZeneca's Faslodex
30 October 2012
Mixed NICE views on Faslodex and RoActemra
14 December 2011
UK’s NICE says no to AstraZeneca breast cancer drug Faslodex
10 November 2011
Approval of diabetes drugs from AstraZeneca/B-MS and Novo Nordisk supported by EU’s CHMP; Faslodex cleared in Japan
26 September 2011
AstraZeneca breast cancer drug Faslodex not good use of NHS resources, says NICE draft guidance
24 August 2011
Strong data on AstraZeneca’s vandetanib in advanced papillary or follicular thyroid cancer; FDA clears new Faslodex dosage
13 September 2010
Positive new data Ph III on AstraZeneca’s Faslodex presented at SABC; drugmaker seeks more partnerships
11 December 2009
AZ's Faslodex improves disease control
22 December 2008
High dose Faslodex impresses in breast cancer trial
24 December 2007
Pfizer data indicates differences between steroidal and non-steroidal aromatase inhibitors
26 March 2007
Strong data for AstraZeneca's Faslodex
22 December 2006
Faslodex as advanced breast cancer drug
13 March 2006
AstraZeneca's Faslodex and Arimidex little different
19 December 2005
Stock Commentary - Europe
29 March 2004
AstraZeneca's Faslodex meets unmet need in breast cancer
29 March 2004
AstraZeneca's Faslodex cleared in EU
22 March 2004
Biomira outlines 2003 milestones
5 January 2004
Stock Commentary - Week to Feb 17 - Europe
24 February 2003
Update: AstraZeneca to do safety trial of Iressa
17 February 2003
AstraZeneca files Faslodex in Europe
17 February 2003
2002's crop of new product launches backs up R&D fears
10 February 2003
Pivotal Faslodex trials published
19 August 2002
AstraZeneca confident about overcoming loss of Prilosec revenues
11 February 2002
AstraZeneca files for Faslodex in USA
30 March 2001
AstraZeneca showcases new oncology drugs
6 April 2000
AstraZeneca unveils promising portfolio with 57 NCEs
14 December 1999
Positive 1st-qtr news from AstraZeneca
26 May 1999
Astra & Zeneca Join In Euro Merger Mania
10 December 1998
Astra & Zeneca Join In Euro Merger Mania
9 December 1998
UK Scientists Slam Early Closure Of Tamoxifen Trial
9 April 1998
Zeneca Allays Fears Of Near-Term Product Gap
4 December 1997
Showing 1-38 of 38 articles
- 1
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
